Get the Stockscreener App
40.00
2.22%
0.87
After Hours:
40.00
Harmony Biosciences Holdings Inc stock is traded at $40.00, with a volume of 580.38K.
It is up +2.22% in the last 24 hours and up +11.17% over the past month.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.
See More
Previous Close:
$39.13
Open:
$39.12
24h Volume:
580.38K
Relative Volume:
1.48
Market Cap:
$2.27B
Revenue:
$656.11M
Net Income/Loss:
$114.99M
P/E Ratio:
16.26
EPS:
2.46
Net Cash Flow:
$212.78M
1W Performance:
+4.58%
1M Performance:
+11.17%
6M Performance:
+19.12%
1Y Performance:
+22.06%
1-Day Range:
$38.95
$40.40
1-Week Range:
$37.10
$40.40
52-Week Range:
$18.61
$40.40
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
Name
Harmony Biosciences Holdings Inc
Sector
Industry
Phone
(484) 539-9800
Address
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-21-24 | Initiated | Citigroup | Buy |
| Jan-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-25-23 | Downgrade | Goldman | Neutral → Sell |
| Sep-07-23 | Initiated | Berenberg | Buy |
| Apr-20-23 | Initiated | BofA Securities | Neutral |
| Oct-14-22 | Upgrade | Janney | Neutral → Buy |
| Oct-14-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-03-22 | Downgrade | Jefferies | Buy → Hold |
| Jul-13-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-14-22 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-01-21 | Initiated | Oppenheimer | Outperform |
| Nov-04-21 | Initiated | Raymond James | Outperform |
| Sep-23-21 | Initiated | Needham | Buy |
| Mar-29-21 | Upgrade | Goldman | Neutral → Buy |
| Sep-14-20 | Initiated | Goldman | Neutral |
| Sep-14-20 | Initiated | Jefferies | Buy |
| Sep-14-20 | Initiated | Piper Sandler | Overweight |
View All
Harmony Biosciences Holdings Inc Stock (HRMY) Latest News
How to Take Advantage of moves in (HRMY) - Stock Traders Daily
Harmony Biosciences executive sells shares worth over $8,000 - Investing.com
Hsbc Holdings PLC Has $731,000 Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Is Harmony Biosciences Holdings, Inc. (HRMY) the Best Cheap Growth Stock to Buy According to Analysts? - Insider Monkey
Is Harmony Biosciences Holdings, Inc. (HRMY) the Best Cheap Growth Stock to Buy According to Analysts? - Yahoo Finance
Harmony Biosciences (HRMY) Surges 6.7%: Is This an Indication of Further Gains? - MSN
Harmony Biosciences (HRMY) Surges 6.7%: Is This an Indication of Further Gains? - Yahoo Finance
Harmony Biosciences stock hits 52-week high at $39.73 - Investing.com
Harmony Biosciences stock hits 52-week high at $39.73 By Investing.com - Investing.com Canada
HARMONY BIOSCIENCES TO HOST FIRST INVESTOR DAY ON OCTOBER 1, 2024 - StreetInsider.com
HARMONY BIOSCIENCES TO HOST FIRST INVESTOR DAY ON OCTOBER 1, 2024 - StockTitan
Is Harmony Biosciences (HRMY) Stock Undervalued Right Now? - Yahoo Finance
Many Still Looking Away From Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Simply Wall St
Harmony Biosciences (HRMY) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Harmony Biosciences (NASDAQ:HRMY) Earns Buy Rating from Needham & Company LLC - MarketBeat
First Week of November 15th Options Trading For Harmony Biosciences Holdings (HRMY) - Nasdaq
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Purchased by Pacer Advisors Inc. - MarketBeat
Massachusetts Financial Services Co. MA Increases Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Harmony Biosciences Holdings, Inc. (HRMY): Short Seller Sentiment is Bearish - Insider Monkey
Harmony Biosciences Holdings, Inc. (HRMY): Short Seller Sentiment is Bearish - Yahoo Finance
14 Worst 52-Week High Stocks to Buy According to Short Sellers - Insider Monkey
American Century Companies Inc. Grows Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
HARMONY BIOSCIENCES RANKED AMONG TOP 25 FASTEST-GROWING COMPANIE - GuruFocus.com
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Purchased by American Century Companies Inc. - MarketBeat
How the (HRMY) price action is used to our Advantage - Stock Traders Daily
Brokerages Set Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Price Target at $41.33 - MarketBeat
Rhumbline Advisers Has $3.04 Million Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Denali Advisors LLC Makes New $425,000 Investment in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
HARMONY BIOSCIENCES ANNOUNCES US FOOD & DRUG ADMINISTRATION ORPH - GuruFocus.com
Harmony Biosciences (NASDAQ:HRMY) Sets New 12-Month High at $39.46 - MarketBeat
HRMY stock touches 52-week high at $38.53 amid market fluctuations - Investing.com
Harmony Biosciences' (HRMY) "Buy" Rating Reaffirmed at Needham & Company LLC - MarketBeat
HRMY stock touches 52-week high at $38.53 amid market fluctuations - Investing.com Canada
HRMY stock touches 52-week high at $38.53 amid market fluctuations - Investing.com UK
Needham stock maintains Buy rating on Harmony Biosciences stock - Investing.com
Needham stock maintains Buy rating on Harmony Biosciences stock - Investing.com India
Needham stock maintains Buy rating on Harmony Biosciences stock By Investing.com - Investing.com Australia
Needham Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider.com
Rice Hall James & Associates LLC Increases Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
LSV Asset Management Buys 243,100 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Shares Gap Up to $36.89 - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Now Covered by Analysts at UBS Group - Defense World
Neurology-Focused Harmony Biosciences Gains Confidence With Wakix Sales Surge, Strategic Pipeline Expansion, Bullish Analyst Says - Benzinga
Unveiling 6 Analyst Insights On Harmony Biosciences - Benzinga
Harmony Biosciences (NASDAQ:HRMY) Now Covered by UBS Group - MarketBeat
UBS sees strong growth potential in Harmony Biosciences stock with Wakix leading the way - Investing.com India
UBS sees strong growth potential in Harmony Biosciences stock with Wakix leading the way - Investing.com
UBS sees strong growth potential in Harmony Biosciences stock with Wakix leading the way - Investing.com UK
Undervalued Biotech Stocks Ready for a Breakout - Inkl
BMRN: Undervalued Biotech Stocks Ready for a Breakout - StockNews.com
Versor Investments LP Buys New Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Harmony Biosciences Holdings Inc Stock (HRMY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):